These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10592461)

  • 21. Systemic sclerosis. A vascular perspective.
    LeRoy EC
    Rheum Dis Clin North Am; 1996 Nov; 22(4):675-94. PubMed ID: 8923590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
    Cipriani P; Guiducci S; Miniati I; Cinelli M; Urbani S; Marrelli A; Dolo V; Pavan A; Saccardi R; Tyndall A; Giacomelli R; Cerinic MM
    Arthritis Rheum; 2007 Jun; 56(6):1994-2004. PubMed ID: 17530639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis of systemic sclerosis-current concept and emerging treatments.
    Furue M; Mitoma C; Mitoma H; Tsuji G; Chiba T; Nakahara T; Uchi H; Kadono T
    Immunol Res; 2017 Aug; 65(4):790-797. PubMed ID: 28488090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice.
    Taniguchi T; Asano Y; Akamata K; Noda S; Takahashi T; Ichimura Y; Toyama T; Trojanowska M; Sato S
    Arthritis Rheumatol; 2015 Feb; 67(2):517-26. PubMed ID: 25385187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tight skin mouse: an animal model of systemic sclerosis.
    Pablos JL; Everett ET; Norris JS
    Clin Exp Rheumatol; 2004; 22(3 Suppl 33):S81-5. PubMed ID: 15344604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of autoimmunity in the tight skin-2 mouse: a model for scleroderma.
    Gentiletti J; McCloskey LJ; Artlett CM; Peters J; Jimenez SA; Christner PJ
    J Immunol; 2005 Aug; 175(4):2418-26. PubMed ID: 16081813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Searching for a good model for systemic sclerosis: the molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis.
    Cipriani P; Di Benedetto P; Dietrich H; Ruscitti P; Liakouli V; Carubbi F; Pantano I; Berardicurti O; Sgonc R; Giacomelli R
    Arch Med Sci; 2016 Aug; 12(4):828-43. PubMed ID: 27478465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is low molecular weight hyaluronan an early indicator of disease in avian systemic sclerosis?
    Kerje S; Hellman U; Do L; Larsson G; Kämpe O; Engström-Laurent A; Lindqvist U
    Connect Tissue Res; 2016 Sep; 57(5):337-46. PubMed ID: 27135250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Connective tissue metabolism including cytokines in scleroderma.
    Postlethwaite AE
    Curr Opin Rheumatol; 1993 Nov; 5(6):766-72. PubMed ID: 8117540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damage.
    Venneker GT; van den Hoogen FH; Boerbooms AM; Bos JD; Asghar SS
    Lab Invest; 1994 Jun; 70(6):830-5. PubMed ID: 7516986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.
    Asano N; Fujimoto M; Yazawa N; Shirasawa S; Hasegawa M; Okochi H; Tamaki K; Tedder TF; Sato S
    Am J Pathol; 2004 Aug; 165(2):641-50. PubMed ID: 15277237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.
    Yoshizaki A; Yanaba K; Yoshizaki A; Iwata Y; Komura K; Ogawa F; Takenaka M; Shimizu K; Asano Y; Hasegawa M; Fujimoto M; Sato S
    Arthritis Rheum; 2010 Aug; 62(8):2476-87. PubMed ID: 20506342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update on biomarker discovery and use in systemic sclerosis.
    Matsushita T; Takehara K
    Expert Rev Mol Diagn; 2017 Sep; 17(9):823-833. PubMed ID: 28730919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of endogenous endothelin in endothelial dysfunction in murine model of systemic sclerosis: tight skin mice 1.
    Richard V; Solans V; Favre J; Henry JP; Lallemand F; Thuillez C; Marie I
    Fundam Clin Pharmacol; 2008 Dec; 22(6):649-55. PubMed ID: 19049669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Systemic sclerosis: pathophysiology of a multifaceted disease].
    Servettaz A; Agard C; Tamby MC; Guilpain P; Guillevin L; Mouthon L
    Presse Med; 2006 Dec; 35(12 Pt 2):1903-15. PubMed ID: 17159716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasculopathy in scleroderma.
    Asano Y; Sato S
    Semin Immunopathol; 2015 Sep; 37(5):489-500. PubMed ID: 26152638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular players in angiogenesis during the course of systemic sclerosis.
    Cipriani P; Marrelli A; Liakouli V; Di Benedetto P; Giacomelli R
    Autoimmun Rev; 2011 Aug; 10(10):641-6. PubMed ID: 21549220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular pathogenesis of skin fibrosis: insight from animal models.
    Smith GP; Chan ES
    Curr Rheumatol Rep; 2010 Feb; 12(1):26-33. PubMed ID: 20425530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunopathogenesis of scleroderma--evolving concepts.
    Sapadin AN; Esser AC; Fleischmajer R
    Mt Sinai J Med; 2001; 68(4-5):233-42. PubMed ID: 11514910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.